Kirkpatrick, 1988 - Google Patents
Transfer factorKirkpatrick, 1988
View PDF- Document ID
- 14366670785104350741
- Author
- Kirkpatrick C
- Publication year
- Publication venue
- Journal of Allergy and Clinical Immunology
External Links
Snippet
It has been more than 30 years since Dr. HS Lawrence first reported that it was possible to transfer delayed-type hypersensitivity from sensitized donors to unsensitized recipients with lysates of blood leukocytes. During recent years, research from several laboratories has …
- 108010074506 Transfer Factor 0 title abstract description 129
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from micro-organisms
- Y10S530/826—Viruses
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kirkpatrick | Transfer factor | |
| US6083919A (en) | Materials and methods for treating autoimmune disease | |
| Kirkpatrick | Transfer factors: identification of conserved sequences in transfer factor molecules | |
| Pircher et al. | Lower receptor avidity required for thymic clonal deletion than for effector T-cell function | |
| US4803072A (en) | Immunomodulation | |
| Rasmussen et al. | Role of T lymphocytes in cellular immune responses during herpes simplex virus infection in humans. | |
| Engers et al. | Inhibition of T cell-mediated functions by MVM (i), a parvovirus closely related to minute virus of mice. | |
| Germain et al. | Antigen-specific T-cell-mediated suppression. I. Induction of L-glutamic acid (60)-L-alanine (30)-L-tyrosine (10) specific suppressor T cells in vitro requires both antigen-specific T-cell-suppressor factor and antigen | |
| Zuckerman et al. | Immunologic specificity of transfer factor | |
| Wecker et al. | Expression of MuLV GP71-like antigen in normal mouse spleen cells induced by antigenic stimulation | |
| Sun et al. | Suppression of antigen-specific T cell proliferation by measles virus infection: role of a soluble factor in suppression | |
| DeFreitas et al. | Human T-lymphocyte response in vitro to synthetic peptides of herpes simplex virus glycoprotein D. | |
| Hughes et al. | Immunopotentiation of bovine herpes virus subunit vaccination by interleukin-2 | |
| Hiramatsu et al. | Unique T cell Ia antigen expressed on a hybrid cell line producing antigen-specific augmenting T cell factor. | |
| Härfast et al. | Immunoglobulin-independent natural cytotoxicity of Fc receptor-bearing human blood lymphocytes to mumps virus-infected target cells | |
| Lutz et al. | Accessory cell requirements for the generation of cytolytic T lymphocytes | |
| Yoshida et al. | Biologic and antigenic similarity of virus-induced migration inhibition factor to conventional, lymphocyte-derived migration inhibition factor. | |
| Handzel et al. | Immunomodulation of T cell deficiency in humans by thymic humoral factor: From crude extract to synthetic thymic humoral factor-γ2 | |
| Warren et al. | Antigen mediation of a late-acting suppressor T-cell activity. | |
| Chu et al. | Examining the immune response in sentinel lymph nodes of mice and men | |
| Yodoi et al. | Formation of IgE-binding factors by rat T lymphocytes. I. Induction of IgE-binding factors by poly I: C and interferon. | |
| Friedman et al. | MLC-derived human helper factor (s) that promote B cell differentiation: induction, functional characterization, and role of Ia antigens. | |
| Hirashima et al. | The mediation of tissue eosinophilia in hypersensitivity reactions. IV. Production of delayed eosinophil chemotactic factor-A by peritoneal exudate cells from sensitized guinea-pigs in vitro | |
| US5565549A (en) | CD8+ cell antiviral factor | |
| Neu | The role of cellular and humoral factors in infections |